TL;DR
This study reveals that aging bone marrow (BM) cells, specifically macrophages, drive the development of atherosclerosis by promoting the clonal expansion of multiple smooth muscle cell (SMC) progenitors. This process is mediated by a molecular pathway involving reduced TET2, decreased integrin β3, and increased TNF-α signaling, highlighting a critical role for aged BM in dictating plaque composition and severity.
What Problem Does This Paper Address?
Atherosclerosis, a leading cause of death, is strongly linked to aging. While it's known that rare SMC progenitors contribute significantly to atherosclerotic plaques through clonal expansion, the impact of aging on this process and the underlying mechanisms remain unclear. Specifically, how aged cells, particularly those from the bone marrow, influence the clonality of SMCs within atherosclerotic plaques and contribute to disease progression was a significant knowledge gap.
Methods
The researchers employed a multi-faceted approach combining mouse models, molecular biology techniques, and advanced imaging:
- Mouse Models: They utilized genetically modified mice (e.g., Ldlr-/-, Apoe-/-, Myh11-CreERT2, Csflr-Mer-iCre-Mer, ROSA26R reporters, Itgb3 conditional knockouts, Tet2 knockouts) to trace cell lineages and manipulate specific genes. Bone marrow transplantation (BMT) was a key technique to assess the role of aged vs. young BM.
- Fate Mapping and Clonality Analysis: Multi-color reporters (ROSA26R-Rainbow) were used to track the clonal origin of SMCs and macrophages within plaques. This allowed for the quantification of mono- vs. polyclonality.
- Molecular and Epigenetic Analysis: Techniques like Western blotting, qRT-PCR, and hydroxymethyl DNA immunoprecipitation (hMeDIP) were used to measure protein and mRNA levels of key genes (TET2, integrin β3, TNF-α, TNFR1) and assess epigenetic modifications (5hmC).
- Cell Culture Assays: Macrophage-conditioned media were used to study the effects of aged macrophages on SMC migration and proliferation.
- High-Throughput Sequencing: Single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing were performed on monocytes/macrophages to understand gene expression changes associated with aging and Itgb3 deficiency.
- Histology and Imaging: Standard histological techniques (H&E, Oil Red O) and immunofluorescence microscopy were used to analyze plaque morphology, lipid content, and cell distribution.
Datasets
Not explicitly discussed as distinct datasets for training/evaluation in the context of machine learning. The study generated and analyzed data from various experimental conditions using the described methods.
Key Insights and Ideas
- Age of the Bone Marrow is Key: The study strongly suggests that the age of the bone marrow, rather than the age of the SMCs themselves, is the primary determinant of SMC clonality in atherosclerotic plaques. This shifts focus to the systemic influence of aging on the immune microenvironment.
- Macrophages as Orchestrators: Aged macrophages, originating from the bone marrow, appear to be the main drivers of this age-dependent change in SMC clonality.
- Epigenetic Link: TET2-Integrin β3 Axis: A crucial molecular mechanism is uncovered: reduced TET2 in aged myeloid cells leads to decreased 5hmC on the ITGB3 promoter, resulting in lower integrin β3 expression. This epigenetic dysregulation is central to the observed phenotype.
- TNF-α as a Mediator: Low integrin β3 in aged macrophages leads to increased TNF-α signaling, which then acts on SMCs to promote their recruitment and polyclonal expansion.
- Therapeutic Potential: The findings suggest that targeting this pathway, perhaps by restoring integrin β3 function or inhibiting TNF-α, could be a therapeutic strategy for age-related atherosclerosis.
Key Results
- Polyclonal SMC Expansion in Aged Mice: Plaques in aged mice showed a marked shift towards polyclonality of SMC-derived cells, with a more even distribution of clonal colors compared to the dominance of a single clone in young mice.
- Aged BM Induces Polyclonality: Bone marrow transplantation from aged mice into young recipients induced polyclonality of SMC-derived plaque cells, while young BM did not.
- Tet2 Deficiency Mimics Aging: Tet2-deficient BM also led to polyclonal expansion of SMC progenitors, similar to the effects of aged BM.
- Integrin β3 Reduction: Aged human and mouse monocytes/macrophages showed significantly reduced ITGB3 mRNA and protein levels.
- TNF-α Upregulation: Aged BM increased plasma TNF-α levels, and anti-TNF-α treatment reduced SMC-derived plaque cells and promoted single-clone dominance in Itgb3-deficient or aged BM settings.
- Itgb3 Overexpression Attenuates Effects: Overexpressing Itgb3 in aged BM reduced TNF-α levels and led to a single SMC-derived clone dominance, attenuating plaque burden.
Limitations and Future Work
- Complexity of Aging: The authors acknowledge that aging is a complex process with multiple contributing factors. While they highlight a specific pathway, other age-related changes in the BM microenvironment may also play a role.
- Translational Relevance: While human monocytes were analyzed, further studies are needed to fully translate these findings to human atherosclerosis.
- Future Directions: The authors suggest investigating the role of this impaired regulation of clonal expansion by aged BM-derived macrophages in other age-related contexts, such as the aging of other tissues (esophagus, endometrium, skin, bronchi) and in conditions like cirrhosis and neurodegeneration. Further exploration of the interplay between integrin β3, CD47, and downstream signaling in atherosclerosis and aging is also warranted.
Summary updated